Could somebody please gracefully clarify for me if Remestemcel-L is still a viable treatment for a-GVHD?
The panic selling tells me I've missed something in the announcement, yet I cannot see any indication that Remestemcal-L has lost its utility for treating a-GVHD.
Before the blaster dropped the bright idea on using Remestemcel-L for ARDS, RYONCIL was looking really good with the FDA, application for the BLA was fast tracked April 1st. That was only with regards to a-GVHD, nothing to do ARDS.
So can anyone point me to the announcements where:
1: The Remestemcel-L (fast track approved) BLA was hijacked by the ARDS BLA (or clarify when the two became one)
2: The Remestemcel-L treatment was deemed ineffective to treat a-GVHD
FWIW
As a LT holder, MSB's pursuit of a treatment for ARDS always felt a bit disingenuous and "bandwagony" to me. I believed in the treatments and processes undertaken by MSB before SI felt it necessary to cash in on the COVID hype. I still do, yet I have to sit here and wonder why RYONCIL was used for ARDS when so much had been accomplished and so much was on the line with a-GVHD.
- Forums
- ASX - By Stock
- MSB
- Ann: Mesoblast Update on COVID-19 ARDS Trial
Ann: Mesoblast Update on COVID-19 ARDS Trial, page-917
-
-
- There are more pages in this discussion • 159 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.03 |
Change
0.080(8.42%) |
Mkt cap ! $1.176B |
Open | High | Low | Value | Volume |
95.5¢ | $1.03 | 95.0¢ | $43.38M | 42.28M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 72752 | $1.01 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.03 | 205100 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 72752 | 1.010 |
2 | 55322 | 1.005 |
9 | 171702 | 1.000 |
2 | 87426 | 0.995 |
2 | 20525 | 0.990 |
Price($) | Vol. | No. |
---|---|---|
1.030 | 205100 | 2 |
1.035 | 634763 | 10 |
1.040 | 372297 | 5 |
1.045 | 318494 | 9 |
1.050 | 21696 | 6 |
Last trade - 16.10pm 30/08/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, MD & CEO
Anthony Noble
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online